openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings
WARNINGS Sympathomimetic amines should be used judiciously and sparingly in patients with hypertension, diabetes, ischemic heart disease, hypothyroidism, increased intraocular pressure, and prostatic hyperthrophy. Sympathomimetic amines may produce CNS stimulation with convulsions or cardiovascular collapse with accompanying hypertension. The elderly (60 years and older) are more likely to exhibit adverse reaction. Antihistamines may cause excitability, especially in children. A dosages higher than the recommended dose, nervousness, dizziness or sleepiness may occur. Do not exceed recommended dosage.
ADVERSE REACTIONS Sympathomimetic amines may cause tachycardia, palpitations, nervousness, insomnia, restlessness, headache, gastric irritation and irritability. Sympathomimetic amines have been associated with certain untoward reactions including fear, anxiety, tenseness, restlessness, tremor, weakness, respiratory difficulty, dysuria, insomnia, hallucinations, convulsions. CNS depression, arrhythmias and cardiovascular collapse with hypotension. Urinary retention may occur in patients with prostatic hypertrophy. Antihistamines and anticholinergics may cause drowsiness, dizziness, blurred vision and excessive dryness of the nose, throat and mouth.